NCT02274571View on ClinicalTrials.gov

Raising Insulin Sensitivity in Post Menopause

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 11, 2017

Study Completion Date

April 11, 2017

Conditions
Menopause
Interventions
DRUG

TSEC (Tissue-selective estrogen complexes)

Duavee™, combination of CE(conjugated equine estrogens) and BZA (bazedoxifene)

OTHER

Placebo

non active

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
lead

Pennington Biomedical Research Center

OTHER

NCT02274571 - Raising Insulin Sensitivity in Post Menopause | Biotech Hunter | Biotech Hunter